Genetic Technologies Price Prediction
| GENEDelisted Stock | USD 0.77 0.00 0.00% |
Oversold Vs Overbought
62
Oversold | Overbought |
Using Genetic Technologies hype-based prediction, you can estimate the value of Genetic Technologies from the perspective of Genetic Technologies response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Genetic Technologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Genetic because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Genetic Technologies after-hype prediction price | USD 0.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Genetic |
Genetic Technologies After-Hype Price Prediction Density Analysis
As far as predicting the price of Genetic Technologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Genetic Technologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Genetic Technologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Genetic Technologies Estimiated After-Hype Price Volatility
In the context of predicting Genetic Technologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Genetic Technologies' historical news coverage. Genetic Technologies' after-hype downside and upside margins for the prediction period are 0.77 and 0.77, respectively. We have considered Genetic Technologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Genetic Technologies is very steady at this time. Analysis and calculation of next after-hype price of Genetic Technologies is based on 3 months time horizon.
Genetic Technologies Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Genetic Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genetic Technologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Genetic Technologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 6 Events / Month | 5 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.77 | 0.77 | 0.00 |
|
Genetic Technologies Hype Timeline
Genetic Technologies is currently traded for 0.77. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Genetic is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Genetic Technologies is about 0.0%, with the expected price after the next announcement by competition of 0.77. The book value of the company was currently reported as 0.01. The company recorded a loss per share of 0.02. Genetic Technologies last dividend was issued on the 15th of August 2019. The entity had 1:5 split on the 14th of December 2023. Given the investment horizon of 90 days the next estimated press release will be in about 6 days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.Genetic Technologies Related Hype Analysis
Having access to credible news sources related to Genetic Technologies' direct competition is more important than ever and may enhance your ability to predict Genetic Technologies' future price movements. Getting to know how Genetic Technologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Genetic Technologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BIOC | Biocept | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TTOO | T2 Biosystms | (0.04) | 10 per month | 0.00 | (0.34) | 7.69 | (14.29) | 36.38 | |
| HTGM | HTG Molecular Diagnostics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INBS | Intelligent Bio Solutions | 0.13 | 9 per month | 4.62 | 0.01 | 9.93 | (7.97) | 25.53 | |
| IDXG | Interpace Biosciences | 0.00 | 0 per month | 9.49 | 0.12 | 18.81 | (16.19) | 194.90 | |
| BIAF | bioAffinity Technologies, | 0.00 | 0 per month | 0.00 | (0.21) | 5.38 | (10.19) | 32.01 | |
| SQL | SeqLL Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| A | Agilent Technologies | (0.68) | 8 per month | 1.45 | 0.01 | 2.72 | (2.42) | 8.06 | |
| SERA | Sera Prognostics | 0.07 | 8 per month | 0.00 | (0.01) | 10.39 | (8.66) | 31.68 | |
| PRPO | Precipio | (0.14) | 7 per month | 2.76 | 0.01 | 5.26 | (3.88) | 11.89 | |
| MDXH | MDxHealth SA ADR | (0.03) | 3 per month | 3.37 | (0) | 5.56 | (6.29) | 18.80 |
Genetic Technologies Additional Predictive Modules
Most predictive techniques to examine Genetic price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genetic using various technical indicators. When you analyze Genetic charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Genetic Technologies Predictive Indicators
The successful prediction of Genetic Technologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Genetic Technologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Genetic Technologies based on analysis of Genetic Technologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Genetic Technologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Genetic Technologies's related companies.
Story Coverage note for Genetic Technologies
The number of cover stories for Genetic Technologies depends on current market conditions and Genetic Technologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Genetic Technologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Genetic Technologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Genetic Technologies Short Properties
Genetic Technologies' future price predictability will typically decrease when Genetic Technologies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Genetic Technologies often depends not only on the future outlook of the potential Genetic Technologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genetic Technologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 132.2 M | |
| Cash And Short Term Investments | 1 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Genetic Stock
If you are still planning to invest in Genetic Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetic Technologies' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |